Greg Lutz Email

Director, Manufacturing Operations . Fujirebio US

Current Roles

Employees:
373
Revenue:
$93.6M
About
Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD). It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, Fujirebio’s global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network. Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Its IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Fujirebio is today a member of Miraca Group (Miraca Holdings Inc. listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1.200 people in Asia, Europe and America.
Fujirebio US Address
205 Great Valley Parkway
Malvern, PA
United States
Fujirebio US Email

Past Companies

Fujirebio Diagnostics, Inc.Director, Manufacturing Operations
Fujirebio Diagnostics, Inc.Sr. Vice President, Operations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.